Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

94.49 +1.49 (+1.60%)
Streaming Delayed Price Updated: 9:38 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
34 35 Next >
Buy Smart With Software Stocks on the Dip
With tech taking over, software stocks are inevitable winners. But when buying the dip, look for low valuation and high durability. 
Via InvestorPlace
Illumina Collaborates With Nashville Biosciences to Accelerate Medicines Development
SOURCE: Illumina 
Via 3BL Media
Illumina's Nonprofit Partner Future Kings Is Cultivating the Next Generation of STEM Leaders
SOURCE: Illumina 
Via 3BL Media
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
SOURCE: Illumina 
Via 3BL Media
Will Earnings Extend The Rally In Value Stocks?
US stocks extended their decline from the first week of 2022. Bank earnings disappointed investors. Inflation remained high. Investors questioned the strength of the economy to get through the omicron... 
Via Talk Markets
Analyst Ratings For Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE: 
Via Benzinga
Illumina Named One of America's Most JUST Companies for Third Consecutive Year
SOURCE: Illumina 
Via 3BL Media
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
If You Invested $1,000 When Illumina Acquired Solexa, Here's How Much You'd Have Now
Genome sequencing company Illumina Inc (NASDAQ: ILMN) has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006... 
Via Benzinga
Promising Developments in Breast Cancer Treatments Ahead in 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group – So far in 2022, there have already been some impressive developments in the battle against... 
Via FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
Upgrades Citigroup upgraded the previous rating for Solo Brands Inc (NYSE: 
Via Benzinga
Illumina Partners With Agendia to Expand Genomic Testing in Breast Cancer Care
SOURCE: Illumina 
Via 3BL Media
48 Biggest Movers From Yesterday
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT... 
Via Benzinga
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
Piper says Pacific Bio has a new competitor in Illumina amid plans to launch what looks like a consumable allowing long-read sequencing on its analyzers. 
Via Talk Markets
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.... 
Via Benzinga
Illumina Announces New Innovative Partnerships, Along With New Groundbreaking Technologies at 2022 J.P. Morgan Healthcare Conference
SOURCE: Illumina 
Via 3BL Media
$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much
Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 3.83% on an annualized basis. Buying $100 In ILMN: 5 years ago, an investor could have purchased 0.62... 
Via Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo... 
Via Benzinga
Why Are Illumina Shares Trading Higher Today?
At the J.P. Morgan Healthcare Conference, Illumina Inc (NASDAQ: ILMN) said it expects about $4.517 billion, +39% Y/Y in 2021 revenue after the company logged... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut the price target for Netflix, Inc. (NASDAQ: 
Via Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped more than 160 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
5 Stocks To Watch For January 11, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects TD SYNNEX Corporation (NYSE: SNX) to report quarterly earnings at $2.67 per share on revenue of $... 
Via Benzinga
Start Of The Week
British property (real estate) stocks fell today. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Inari Medical (NASDAQ:NARI) stock... 
Via Benzinga
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
From Agendia, Inc.
Via Business Wire
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test
From GRAIL, LLC
Via Business Wire
GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.